Literature DB >> 11056845

Heritability and the comorbidity of attention deficit hyperactivity disorder with behavioral disorders and executive function deficits: a preliminary investigation.

F L Coolidge1, L L Thede, S E Young.   

Abstract

The heritability and comorbidity of attention deficit hyperactivity disorder (ADHD) with conduct disorder (CD), oppositional defiant disorder (ODD), and executive function (EF) deficits were examined in 224 child twins (140 monozygotic and 84 dizygotic). The Coolidge Personality and Neuropsychological Inventory for Children (Coolidge, 1998), a standardized, 200-item, Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994) aligned, parent-as-respondent inventory, assessed psychopathology. Structural equation model fitting revealed that the individual scale heritabilities were substantial: .82 for ADHD, .74 for CD, .61 for ODD, and .77 for EF deficits. The results of the multivariate twin analyses suggest that ADHD shares most of its genetic liability with CD, ODD, and EF deficits. Thus, the findings argue for a common biological risk underlying these commonly comorbid externalizing behavior problems and cognitive deficits. The residual genetic variance provides preliminary support for additional genetic influences underlying CD, ODD, and EF that are independent of ADHD.

Entities:  

Mesh:

Year:  2000        PMID: 11056845     DOI: 10.1207/S15326942DN1703_1

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  34 in total

1.  Posttraumatic stress disorder and the genetic structure of comorbidity.

Authors:  Erika J Wolf; Mark W Miller; Robert F Krueger; Michael J Lyons; Ming T Tsuang; Karestan C Koenen
Journal:  J Abnorm Psychol       Date:  2010-05

2.  [Military service with adult attention deficit hyperactivity disorder: adaptability of affected soldiers on active service in the German Armed Forces].

Authors:  P Zimmermann; M Jenuwein; K H Biesold; A Heinz; A Ströhle
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

3.  The dopamine receptor D4 gene (DRD4) moderates family environmental effects on ADHD.

Authors:  Michelle M Martel; Molly Nikolas; Katherine Jernigan; Karen Friderici; Irwin Waldman; Joel T Nigg
Journal:  J Abnorm Child Psychol       Date:  2011-01

4.  BEHAVIORAL GENETICS: THE SCIENCE OF ANTISOCIAL BEHAVIOR.

Authors:  Laura A Baker; Serena Bezdjian; Adrian Raine
Journal:  Law Contemp Probl       Date:  2006

5.  Executive functions and substance use: Relations in late adolescence and early adulthood.

Authors:  Daniel E Gustavson; Michael C Stallings; Robin P Corley; Akira Miyake; John K Hewitt; Naomi P Friedman
Journal:  J Abnorm Psychol       Date:  2017-01-02

6.  Co-existing psychiatric problems in ADHD in the ADORE cohort.

Authors:  Hans-Christoph Steinhausen; Torunn Stene Nøvik; Gisli Baldursson; Paolo Curatolo; Maria J Lorenzo; Rob Rodrigues Pereira; Stephen J Ralston; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

7.  Meta-Analyses of Externalizing Disorders: Genetics or Prenatal Alcohol Exposure?

Authors:  Leah Wetherill; Tatiana Foroud; Charles Goodlett
Journal:  Alcohol Clin Exp Res       Date:  2017-11-27       Impact factor: 3.455

8.  COMT and DAT1 polymorphisms moderate the indirect effect of parenting behavior on youth ADHD symptoms through neurocognitive functioning.

Authors:  Julia E Morgan; Barbara Caplan; Irene Tung; Amanda N Noroña; Bruce L Baker; Steve S Lee
Journal:  Child Neuropsychol       Date:  2017-07-04       Impact factor: 2.500

9.  Are There Executive Dysfunction Subtypes Within ADHD?

Authors:  Bethan A Roberts; Michelle M Martel; Joel T Nigg
Journal:  J Atten Disord       Date:  2016-07-28       Impact factor: 3.256

10.  A Hierarchical Factor Model of Executive Functions in Adolescents: Evidence of Gene-Environment Interplay.

Authors:  James J Li; Tammy A Chung; Michael M Vanyukov; D Scott Wood; Robert Ferrell; Duncan B Clark
Journal:  J Int Neuropsychol Soc       Date:  2014-12-15       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.